This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages without signing in

Disorders of glucose metabolism

Authoring team

Poor glucose metabolism leads to diabetes mellitus. Uncontrolled diabetes poses a significantly increased risk of developing macrovascular disease, especially coronary, cerebrovascular, and peripheral vascular disease. It also increases the chances of microvascular disease, including retinopathy, nephropathy, and neuropathy.

Diabetes is classified into two types-

Type 1 DM- due to deficient insulin secretion. Key features of this type are;

  • Immune-mediated in over 90% of cases.
  • It can occur in any age group but is most common in children and young adults.
  • Circulating insulin is virtually absent, leading to a catabolic state with exogenous insulin required for treatment.

Type 2 DM- due to insulin resistance with a defect in compensatory insulin secretion. Key features of this type are;

  • This condition occurs predominantly in adults but is now increasingly present in children and adolescents.
  • Genetic and environmental factors combine, leading to insulin resistance and beta-cell loss.
  • Treatment entails lifestyle changes and oral anti-diabetic drugs.

Reference

  1. NICE. Type 1 diabetes in adults: diagnosis and management. NICE guideline NG17. Published August 2015, last updated August 2022
  2. NICE. Type 2 diabetes in adults. Quality standard QS209. Published March 2023

Related pages

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2025 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.